Early Onset Active Inflammatory Bowel Disease and Psychiatric Comorbidities
Author Information
Author(s): Nadeem Ahmed MD, Sydney Donohue MD, Fatima Zehra Shah MD, Jaime Abraham Perez PhD, Elleson Harper BS, Preetika Sinh MD, Ruthvik Padival MD, Gregory Cooper MD, Jeffry Katz MD, Fabio Cominelli MD, PhD, Miguel Regueiro MD, Emad Mansoor MD
Primary Institution: Cleveland Clinic Foundation
Hypothesis
Patients with active IBD early in their disease course experience increased psychiatric disease severity, comorbid psychiatric diagnoses, and increased psychotropic and nonpsychotropic medication usage.
Conclusion
Active IBD shortly after the IBD diagnosis is associated with a higher incidence of psychiatric comorbidities.
Supporting Evidence
- Patients with active IBD had significantly higher odds of developing major depressive disorder and anxiety disorder.
- Patients with active IBD were more likely to use psychotropic medications, including antidepressants and antipsychotics.
- Routine screening for mental health disorders is recommended for IBD patients due to high prevalence.
Takeaway
If someone gets inflammatory bowel disease (IBD) early on and it’s active, they are more likely to have mental health issues and need medicine for it.
Methodology
Retrospective cohort study using the TriNetX database to analyze IBD patients based on disease activity and psychiatric outcomes.
Potential Biases
Potential bias from excluding patients with prior psychiatric diagnoses and reliance on database coding.
Limitations
Use of billing codes may underestimate psychiatric comorbidities; retrospective design limits causality; potential confounding from steroid use.
Participant Demographics
Mean age 43.7 years; 48.4% female; 70.2% white.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI, 2.14-2.51
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website